Children’s Mpox Shots Arriving
Surging mpox cases in East, West and Central Africa prompted the World Health Organization to once again make the infection a ...
China's top drug regulator has recently approved clinical trials of a mpox vaccine developed by the domestic drugmaker ...
HealthDay on MSN4h
Who's Most Likely to Get the Mpox Shot in U.S.?When an outbreak of mpox first hit the United States in 2022, a vaccine called Jynneos was available to help protect the most ...
It’s déjà vu for Siga Technologies and its smallpox antiviral Tpoxx. At an interim analysis of a second mpox trial, the drug ...
Siga Technologies' antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among ...
As a result of the preliminary STOMP data – which gave the chances of a positive outcome from the study at less than 1% – the ...
After African countries struggled to get testing kits during the COVID-19 pandemic, officials vowed to make the continent ...
As a second wave of the viral disease looms, Rutgers Health researchers call for more studies on long-term immunity.
The antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild ...
STOMP is a randomized, controlled, double-blind trial to evaluate the safety and effectiveness of Tpoxx for treating mpox. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback